trial · primary record
Rinzimetostat
Metastatic Castration Resistant Prostate Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2030-09 |
| Primary endpoint | Radiographic Progression Free Survival assessed by blinded independent central review (BICR) per RECIST v1.1 and Prostate Cancer Clinical Trials Working Group 3 (PCWG3) |
| Registry ID | NCT07723248 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:47.840Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07723248
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.